510(k) · Cleared
ClearedMetal-on-Metal Hip Systems-Additional Contraindications
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Biomet Manufacturing, Inc. · KWA Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component)
Cleared on May 18, 2012 as substantially equivalent to K993438 (Biomet, Inc., 2000) and 7 other predicates after a 196-day review. Its family tree reaches back 6 generations to 1988.
- Decided
- May 18, 2012
- Review
- 196 days
- Class
- Class III
- Product code
- KWA
- Recalls
- None
- Predicates
- 8
Its longest line of descent runs back 6 generations to K881288 (1988). 50 ancestors in all, the oldest K830313 (1983). No later device cites it as a predicate yet.
- Root · 6 generations backK881288 Corin Modular Moore StemOrthopedic Systems, Inc. · 1988
- 5 generations backK960538 Opteon UnipolarExactech, Inc. · 1996
- 4 generations backK984028 The New Bio-Moore Endo HeadsBiomet, Inc. · 1999
- 3 generations backK042037 M2A Magnum SystemBiomet, Inc. · 2004
- 2 generations backK061423 M2A Magnum 12/14 Taper Inserts and One-Piece Modular HeadsBiomet Manufacturing Corp · 2006
- 1 generation backK082446 Biomet Metal-on-Metal Hip Systems- Expanded ContraindicationsBiomet, Inc. · 2008 · Recalled
- This deviceK113271 Metal-on-Metal Hip Systems-Additional ContraindicationsBiomet Manufacturing, Inc. · 2012
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −6 | K881288 | Corin Modular Moore Stem | Orthopedic Systems, Inc. | 1988 | — |
| −5 | K960538 | Opteon Unipolar | Exactech, Inc. | 1996 | — |
| −4 | K984028 | The New Bio-Moore Endo Heads | Biomet, Inc. | 1999 | — |
| −3 | K042037 | M2A Magnum System | Biomet, Inc. | 2004 | — |
| −2 | K061423 | M2A Magnum 12/14 Taper Inserts and One-Piece Modular Heads | Biomet Manufacturing Corp | 2006 | — |
| −1 | K082446 | Biomet Metal-on-Metal Hip Systems- Expanded Contraindications | Biomet, Inc. | 2008 | 1 |
| 0 (this device) | K113271 | Metal-on-Metal Hip Systems-Additional Contraindications | Biomet Manufacturing, Inc. | 2012 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1983 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1991 | 1 | 0 |
| 1994 | 6 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 7 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 0 |
| 2003 | 3 | 0 |
| 2004 | 1 | 0 |
| 2005 | 2 | 0 |
| 2006 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in KWA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (8)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K993438 | Metal on Metal Acetabular SystemSummary page 1…d, porous-coated uncemented prosthesis. Legally Marketed Devices To Which Substantial Equivalence Is Claimed: K993438 - Metal-On-Metal Acetabular Component K002379 - M2a Ringloc Acetabular Liner KO 11110 - M2a Acetabular Syst… | 2000 |
| * | K002379 | M2A 28MM Ringloc LinerSummary page 1…coated uncemented prosthesis. Legally Marketed Devices To Which Substantial Equivalence Is Claimed: K993438 - Metal-On-Metal Acetabular Component K002379 - M2a Ringloc Acetabular Liner KO 11110 - M2a Acetabular System K042037 - M2a Magnum System K042… | 2000 |
| * | K011110 | M2A Acetabular System | 2001 |
| * | K042037 | M2A Magnum SystemSummary page 1…aimed: K993438 - Metal-On-Metal Acetabular Component K002379 - M2a Ringloc Acetabular Liner KO 11110 - M2a Acetabular System K042037 - M2a Magnum System K042841 - M2a / C2a Acetabular System K06 1423 - M2a Magnum 12/14 Taper Inserts and One… | 2004 |
| * | K042841 | M2A/C2A Acetabular SystemSummary page 1…etal Acetabular Component K002379 - M2a Ringloc Acetabular Liner KO 11110 - M2a Acetabular System K042037 - M2a Magnum System K042841 - M2a / C2a Acetabular System K06 1423 - M2a Magnum 12/14 Taper Inserts and One-Piece Modular Heads K062995… | 2004 |
| * | K061423 | M2A Magnum 12/14 Taper Inserts and One-Piece Modular HeadsSummary page 1…a Ringloc Acetabular Liner KO 11110 - M2a Acetabular System K042037 - M2a Magnum System K042841 - M2a / C2a Acetabular System K06 1423 - M2a Magnum 12/14 Taper Inserts and One-Piece Modular Heads K062995 - M2a Magnum Tni-Spike Acetabular Component… | 2006 |
| * | K062995 | M2A-Magnum Tri-Spike Acetabular ComponentSummary page 1…K042037 - M2a Magnum System K042841 - M2a / C2a Acetabular System K06 1423 - M2a Magnum 12/14 Taper Inserts and One-Piece Modular Heads K062995 - M2a Magnum Tni-Spike Acetabular Component K082446 - Biomet Metal-On-Metal Systems - Expanded Contraindications Mail… | 2006 |
| * | K082446 | Biomet Metal-on-Metal Hip Systems- Expanded ContraindicationsSummary page 1…tabular System K06 1423 - M2a Magnum 12/14 Taper Inserts and One-Piece Modular Heads K062995 - M2a Magnum Tni-Spike Acetabular Component K082446 - Biomet Metal-On-Metal Systems - Expanded Contraindications Mailing Address: Shipping Address: P.O. Box 587… | 2008 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 24 years and passes through 5 companies; a new generation was cleared every 3.6 years on median.
- 4 of the 50 ancestors have a recall of any class.
- 6 other devices also cite its predicate K993438.
How does its category compare?
All KWA devicesKWA Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component): FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.
FDA decisions per year · KWA
4in 2012
2026 to Oct 25, outlined.
Median 510(k) review, days · KWA
76in 2012
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · KWA
19in 2023
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · KWA
1,216in 2025
MAUDE reports naming product code KWA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 8 | 74 | 0 | 213 |
| 2008 | 9 | 57 | 13 | 762 |
| 2009 | 7 | 139 | 0 | 820 |
| 2010 | 6 | 167 | 84 | 3,348 |
| 2011 | 11 | 101 | 28 | 17,737 |
| 2012 | 4 | 76 | 21 | 24,601 |
| 2013 | 0 | — | 1 | 20,020 |
| 2014 | 0 | — | 0 | 16,494 |
| 2015 | 0 | — | 0 | 12,339 |
| 2016 | 0 | — | 1 | 7,872 |
| 2017 | 0 | — | 1 | 6,847 |
| 2018 | 0 | — | 1 | 6,388 |
| 2019 | 0 | — | 2 | 7,628 |
| 2020 | 0 | — | 1 | 4,538 |
| 2021 | 0 | — | 0 | 2,064 |
| 2022 | 0 | — | 0 | 1,617 |
| 2023 | 0 | — | 19 | 1,474 |
| 2024 | 0 | — | 0 | 1,168 |
| 2025 | 0 | — | 0 | 1,216 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
1. Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis. 2. Rheumatoid arthritis. 3. Correction of functional deformity. 4. (a) Revision procedures where other treatment or devices have failed (M2a-Taper™ and M2a-Ringloc™). (b) Revision of previously failed total hip arthroplasty (M2a-Magnum™ and M2a-38™). 5. Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head…
Read the full statement (116 words)
1. Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
2. Rheumatoid arthritis.
3. Correction of functional deformity.
4. (a) Revision procedures where other treatment or devices have failed (M2a-Taper™ and M2a-Ringloc™).
(b) Revision of previously failed total hip arthroplasty (M2a-Magnum™ and M2a-38™).
5. Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques.
The components of the M2a Magnum™ system were also cleared for diastrophic variant, fracture of the pelvis, fused hip, Legg Perthes, slipped capital epiphysis, subcaptial fractures, and traumatic arthritis indications. The M2a-Taper™ Metal-on-Metal Hip Joint Replacement Prosthesis are intended for use in cemented and non-cemented primary and revision hip joint arthroplastic procedures.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K113271 · printed Nov 3, 2026
Cite this page
510(k) Report. “K113271: Metal-on-Metal Hip Systems-Additional Contraindications.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K113271
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026